Thinking about CRH (Corticotropin-releasing hormone) and ME/CFS

ScoutB

Moderator
Staff member
Making a thread to start collecting some of the CRH ideas floating around. Everyone free to add anything that seems relevant. Note there is also jnmaciuch's Peripheral neurons, CRH, and sickness behavior thread, which is a bit more focused.

I'll probably come back and clean up this first post later. For now, it's going to include a todo list of stuff I've found as I'm looking at the old cortisol research (some of which looked into CRH). For instance, Cleare mentions 4 studies where CFS patients were administered CRH. All seem to have found totally different results. Not sure if there's any meaning to be wrung out of that (or if that's an interesting question to ask in the first place) but maybe I'll check them out at some point:

Other CRH things we might want to think about/look into in more detail:
As mentioned in the BTN2A2 and BTN3A3 (BTN2A1) thread:
Discussion of other roles for CRH came up on this thread I think. We may need a CRH thread. Nightsong has picked up a paper in Science Signalling - on the miscellaneous research findings thread - that indicates CH may be very relevant aside from an HPA axis role.
(Nightsong's post is here)

The earlier conversation being referenced in that thread included this suggestion:
My guess is that there may be a lot of evidence from elsewhere indicating that CRH is not just the lord and master of cortisol production in the way students may be taught. Hypothalamic damage produces a range of clinical pictures including polyphagy with morbid obesity and growth hormone failure but I am not sure that it commonly leads to hypocortisolism. I rather suspect that CRH may have a more subtle role in cortisol regulation and, importantly, other roles, that we tend to ignore. I wouldn't be surprised if CRH knockouts had fairly normal cortisol levels.

So if we take the post mortem findings on CRH cells seriously (but not as gospel), which seems fair, and add in what we know about narcolepsy (where there isn't symptomatic hypocortisolism either) then my guess is that we should be thinking in terms of some other regulatory role of CRH that has been overlooked. that might have to do with sleep cycles, lipid metabolism, leptin, or whatever.

For completeness: here's the thread on the University of Amsterdam autopsy study that kicked off our interest in CRH.
 
Last edited:
Was trying to answer a question about cortisol and got distracted reading this paper:
Sex differences in stress responses: a critical role for corticotropin-releasing factor
The authors seem to be assuming that women (as well as female mice, rats, and marmosets) get more 'stressed' than men, and cite the higher rates of diagnosed depression, anxiety etc. in women (oddly they do not cite any studies on the gender breakdown of depression in marmosets). I don't know if I love that framing, but I found a few of the results they quoted interesting enough they might be worth checking out.

Oh and CRF = corticotropin-releasing factor = corticotropin-releasing hormone = CRH.

CRF levels in CSF are thought to reflect extrahypothalamic release of CRF and do not correlate well with plasma cortisol levels [31]

Sex differences in CRF receptors
CRF dose-dependently impaired sustained attention in both male and female rats. However, the effect of CRF on sustained attention in females was dependent on the estrous cycle [60]. When females were in diestrus, where ovarian hormones are low, CRF profoundly disrupted attention. However, when females were in cycle phases characterized by elevated levels of ovarian hormones, CRF had no effect on attention [60].

This might be useful to keep in mind for the various ACTH-challenge studies we see done with suboptimal gender-matching:
In healthy humans, an intravenous CRF challenge increases ACTH levels more in women than men, suggesting heightened sensitivity to CRF in women [64].

Evidence for sex differences in CRF receptors first comes from binding studies. Specifically, CRF1 receptor binding in regions of the amygdala and cortex is higher in adult female rats, while CRF2 receptor binding is higher in regions of the amygdala and hypothalamus in male rats [65, 66]. Interestingly, many of these changes in binding emerge following puberty, implicating pubertal hormone surges in these sex differences [65, 66].

In addition to sex differences in CRF receptor distribution in different types of neurons, we identified sex differences in CRF1 receptor localization within neurons in the locus coeruleus (LC)-arousal center. During a stressful event, CRF is released into the LC where it binds to CRF1 receptors [70,71,72]. This receptor activation causes LC neurons to increase their firing rate, thereby releasing norepinephrine into the forebrain to increase arousal [70,71,72,73].

Typically, activation of this circuit increases alertness to facilitate responding to stressors. However, overactivation of the circuit can lead to the dysregulated state of hyperarousal, which is characterized by restlessness, lack of concentration, and disrupted sleep [74, 75].
Curious if that looks at all like wired-but-tired.

One cellular mechanism that compensates for excessive CRF release is receptor internalization. During internalization, β-arrestin2 binds to the CRF1 receptor, initiating its trafficking from the plasma membrane to the cytosol where the receptor can no longer be activated [76,77,78,79,80].

In male rats, acute swim stressor exposure causes β-arrestin2 to bind to the CRF1 receptor, an effect accompanied by CRF1 receptor internalization in LC dendrites [81, 82]. However, β-arrestin2 binding and internalization are not observed following exposure to swim stress in female rats [82]. Further, studies in CRF-OE mice with overexpression throughout their lifespan revealed a similar pattern of CRF1 receptor internalization in LC dendrites of males, but not females (Fig. 1c) [83]. This lack of internalization in females may render their LC neurons more sensitive to conditions of excessive CRF release.

Accordingly, overexpression of CRF induces greater cAMP-PKA signaling in female than in male mice [84, 85]. In the LC, this increased CRF1 receptor signaling through the cAMP-PKA pathway in females is associated with increased sensitivity to CRF [84].

Sex differences in CRF expression and the regulation of CRF effects
CRF neurons express NMDA receptors, suggesting glutamatergic regulation of these cells [109]. Knocking out Grin1 subunits of the NMDA receptor results in a loss of NMDA function, and mice genetically modified so that Grin1 is deleted specifically from their CRF-containing neurons have been produced [110,111,112]. These mice display increased fear expression and social withdrawal if they are male [111, 112]. However, female mice are unaffected by this loss of NMDA receptor function in CRF neurons [111]. Thus, glutamatergic regulation of CRF neurons via NMDA receptors appears sex-specific.
 
Connecting some of our interests: apparently CRH is required to activate the locus coeruleus during hypotensive stress (in rats anyway).

Normally, the locus coeruleus activates and releases norepinephrine in response to hypotension. Researchers induced hypotension by injecting the rats with a vasodilator (nitroprusside) and then monitored this response with and without also injecting a CRH antagonist (specifically: a competitive CRF2 receptor antagonist). Blocking the action of CRH blocked the norepinephrine response.

They also say that the CRH release is probably local to the locus coeruleus (rather than coming from the hypothalamus) because they tried inducing hypotension after first injecting dexamethasone (a cortisone-style steroid that suppresses hypothalamic CRH release) and this didn't alter the norepinephrine response. I guess, to be sure of this, I'd like to know if we're sure an acute stressor like hypotension wouldn't override the normal steroid->CRH negative feedback loop.

On the other hand, they induced a different kind of stress (bladder distension), known to activate the locus coeruleus, and found the blocking of CRH seemed to have no effect on that response. (I gather the reason these signalling systems have so many steps is to allow for this kind of decision tree processing to happen?)

Locus coeruleus activation by physiological challenges (Page, 1994) | Sci-hub
(This seems to be one of at least three papers by the same author on this topic - 1991, 1993)
 
Despite the interesting findings from brain tissue samples from the Netherlands Brain Bank, I don't think we have any evidence of reduced CRH in cerebrospinal fluid in ME/CFS?

There was this study - small and flawed, but it found CRH levels were not abnormal in people with CFS (click the arrow to go to the forum thread)

Cerebrospinal fluid CRH levels in patients were no different from control values (8.4 +/- 0.6 vs. 7.7 +/- 0.5 pmol/L; P = NS).
 
Last edited:
This paper may be relevant when thinking about the Amsterdam results:

Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters, 2001
Several lines of evidence suggest a dysregulation of the adrenocortical (HPA) system with hypersecretion of CRH is associated with suicidal behavior. However, controversial results have emerged from the determination of corticotropin-releasing hormone (CRH) concentrations in the lumbar cerebrospinal fluid (CSF) of suicide attempters probably due to methodological differences.

We simultaneously measured CRH concentrations in the CSF and in the plasma of 41 psychiatric in-patients with different diagnoses (affective disorder, schizophrenia, personality disorders, adjustment disorder, substance abuse) and eight neurological control subjects. We also measured plasma cortisol concentrations because data from animal experiments suggest that cortisol may influence CSF CRH concentrations.

The major finding was that patients who attempted suicide prior to admission had significantly lower CSF CRH concentrations than psychiatric patients without suicidal behavior.

CRH concentrations were significantly higher in the CSF than in plasma in both, psychiatric patients and neurological control subjects. There was no significant difference between suicide attempters and patients with acute suicidal ideations. The latter group showed a trend towards lower CSF CRH concentrations compared with the neurological control subjects. Patients with affective disorder alone as well as patients with multiple diagnoses, but not schizophrenic patients, showed significantly lower CSF CRH concentrations than neurological control subjects. Plasma CRH and plasma cortisol concentrations did not differ among diagnostic groups or between suicide attempters vs. non-attempters. Further studies with more homogeneous samples, drug-free patients and with simultaneous assessment of various parameters of the HPA system are warranted.

There's a paywall, but this is in the snippets:
It has to be taken into consideration that quantitative determinations of CRH concentration in cisternal CSF of suicide victims has several methodological limitations including post-mortem delay, duration of agony, cause of death and psychopharmacological medication.
 
We need a way to explain the rapid weight loss that can occur at the start of this illness without GI symptoms. My weight dropped from 8 stone to 7 stone over the first 6 months and I was still eating okay. What is going wrong in the hypothalamus?
 
Despite the interesting findings from brain tissue samples from the Netherlands Brain Bank, I don't think we have any evidence of reduced CRH in cerebrospinal fluid in ME/CFS?
Yeah, it's perplexing and I've been wondering where to look for more background. That 2001 paper looks like a useful reference.

Is there public info on if the Netherlands Brain Bank study checked CRH in the cerebrospinal fluid? Would we expect it to align with the tissue results? (I know they reported CSF cortisol was extremely low and we've been puzzled by that as well.)

I was trying to figure out if the NIH study looked at CRH in the cerebrospinal fluid and it looks like maybe they didn't? At least if I'm understanding these lists of metabolites @forestglip posted at one point.

Another null-ish datapoint on CRH in this small study SNT found:
For comparison, there was 2006 study of CSF CRH in fibromyalgia Cerebrospinal Fluid Corticotropin-Releasing Factor Concentration is Associated with Pain but not Fatigue Symptoms in Patients with Fibromyalgia (2006), looking at men and women. (Women were further divided into those self-reporting previous sexual abuse or not, but they only had 7 and 9 respectively).

They found elevated CSF CRH levels in men and in women not reporting abuse, but not elevated (top of normal range) in women who did report abuse. None of the patient groups had low levels of CRH in CSF.
 
Some methodological thoughts based on papers about CRH in depression.

There's some papers that argue that CRH in the CSF originates mostly from the spinal cord, and thus, may not be a good indicator for hypothalamic abnormalities [1]. So normal CRH levels in the CSF may not tell us much about the hypothalamus.
CSF CRH concentrations rose progressively during the experiment in both groups, suggesting a diurnal rhythm and, possibly, response to a test meal. CRH had a very brief half-life in CSF (less than 10 min), suggesting that the spinal cord is the origin of CRH in lumbar CSF.

However, not everyone agrees [3].
In the present review, we describe the evidence suggesting that CRF is hypersecreted from hypothalamic as well as from extrahypothalamic neurons in depression, resulting in hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and elevations of cerebrospinal fluid (CSF) concentrations of CRF.

Unsurprisingly, there's also large diurnal variation, which has to be taken into account (especially when sample sizes are smaller) [2]
A significant diurnal variation in CSF IR-CRH levels was observed (P < 0.001), with highest levels between 1830-2330 h and lowest levels around 0730 h.

[1] Geracioti et al. (1992). J Clin Endocrinol Metab 74(6):1325–1330. https://scilit.com/publications/7a4520d23f1fab8ea1b0f914e3869fc8

[2] Kling et al. (1994). J Clin Endocrinol Metab 79(1):233–239. https://doi.org/10.1210/jcem.79.1.8027234

[3] Arborelius et al. (1999). J Endocrinol 160(1):1–12. https://doi.org/10.1677/joe.0.1600001
 
Last edited:
Despite the interesting findings from brain tissue samples from the Netherlands Brain Bank, I don't think we have any evidence of reduced CRH in cerebrospinal fluid in ME/CFS?

I am not expecting CRH production to be low and I suspect Felipe may not either. Something paradoxical looks to be going on at the hypothalamic level - one of the Dinan papers touches on this.
 
I am not expecting CRH production to be low and I suspect Felipe may not either.
Reading the literature, it seems that the manner of death might create histology artefacts. Things that stress the body (and dying is inherently a stress on the body, even when death is peaceful) can cause stored CRH to be ejected from the hypothalamus vesicles, and there isn't time for the body to produce more.

I'm not sure why there would be differences between ME/CFS samples and samples from controls, but perhaps there can be differences in the manner of death.
 
Last edited:
Reading the literature, it seems that the manner of death might create histology artefacts. Things that stress the body (and dying is inherently a stress on the body, even when death is peaceful) can cause stored CRH to be ejected from the hypothalamus vesicles, and there isn't time for the body to produce more.

I'm not sure why there would be differences between ME/CFS samples and samples from controls, but perhaps there can be differences in the manner of death.
I think we discussed this on the CRH autopsy thread somewhere. There was a T1 narcolepsy study showing no overlap at all between cases and controls similar to Felipe's study. They did list manner of death and it seemed an equal mixed bag. It's not a perfect comparison of course, only one person in the control group underwent legal euthanasia for example. Though if cause of death was a significant driver then I would expect at least some overlap for the proportion in each group that died of cardiac issues.

 
Last edited:
I think we discussed this on the CRH autopsy thread somewhere. There was a T1 narcolepsy study showing no overlap at all between cases and controls similar to Felipe's study. They did list manner of death and it seemed an equal mixed bag. It's not a perfect comparison of course, only one person in the control group underwent legal euthanasia for example. Though if cause of death was a significant driver then I would expect at least some overlap for the significant proportion in each group that died of cardiac issues.

Do we know anything about tissue handling or medications that could effect systemic differences? The study is from 2022 and the group is from Leiden, do you know more about their ongoing work @fcorreadasilva (one of their more recent case reports in T2 narcolepsy was recently published)?
 
Do we know anything about tissue handling or medications that could effect systemic differences? The study is from 2022 and the group is from Leiden, do you know more about their ongoing work @fcorreadasilva (one of their more recent case reports in T2 narcolepsy was recently published)?
The tissue from the narcolepsy study came from the Netherlands Brain Bank, as the ME/CFS one - so autopsy protocols and tissue handling was harmonic.

I never read the medicla files of narcolepsy donors, so cannot comment now about it.
 
I am not expecting CRH production to be low and I suspect Felipe may not either. Something paradoxical looks to be going on at the hypothalamic level - one of the Dinan papers touches on this.
I think it is also important to mention something else here: we look cortisol from from ventricular CSF. In living patients, we collect lumbar CSF for analysis. The lumbar extraction is not the default in autopsies cases, as there are some pratical challenges with that.

We never mesuared CRH itself in the CSF. We hope that once we can start processing other brain regions, we can look at different sites where CRH is also expressed and understand if this is hypothalamus specific or not.
 
"In NT1, there was: a 234% increase in the percentage of CRH cells co-expressing AVP"
Activated Wake systems in narcolepsy type 1

A possible explanation of normal basal level in NT1. I am curious to know if there could be similar findings for us.
It is important to note that the ME/CFS findings have not yet been peer-reviewed, so please keep this in mind when interpreting the results.

Our findings actually show the opposite: CRH-expressing neurons in ME/CFS show lower co-localization with AVP.

Another important consideration is that, given the substantial numerical difference in CRH-expressing neurons, even a relatively small variation in the number of co-expressing neurons could have a disproportionate impact on the results. I cnanot comment on the narcolepsy study though.
 
Back
Top Bottom